Hemodynamic Support Devices

This hemodynamic support systems channel includes content on intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or TandemHeart, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices (VAD). This channel also includes use of these devices in support of patients in cardiogenic shock and advanced heart failure.

UM School of Medicine researchers detail inflammatory process and heart damage in Lancet Study in preparation for future transplants

News | Heart Failure

Lessons Learned from World’s First Successful Transplant of Genetically-Modified Pig Heart into Human Patient

June 30, 2023 — A new study published in The Lancet has revealed the most extensive analysis to date on what led to the ...

June 30, 2023

Clinical trial establishes Lankenau as one of the most comprehensive heart valve centers nationally by offering yet another alternative to open-heart surgery

News | Structural Heart

Lankenau Medical Center Performs First Minimally Invasive Procedure for Aortic Regurgitation in Philadelphia Region

June 22, 2023 — Lankenau Medical Center, part of Main Line Health, has performed the first minimally invasive catheter ...

June 22, 2023

News | Ventricular Assist Devices (VAD)

Magenta Medical Initiates Early Feasibility Study with World’s Smallest Heart Pump in Leading NY Cardiology Centers

June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...

June 07, 2023

XenoSim project will establish the new field of ‘computational cardiac xenotransplantation’ and establish pioneering computational techniques with significant implications for a range of scientific disciplines

News | Heart Failure

University College Dublin Researcher Receives ERC Funding to Unlock Insights Into Pig-to-human Heart Transplants

June 2, 2023 — Dr. Philip Cardiff, Associate Professor at University College Dublin's School of Mechanical and Materials ...

June 02, 2023

The objective of this study was to assess the safety and efficacy of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery (PA).

News | Drug-Eluting Balloons

Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

May 30, 2023 — Twelve-month results from the SELUTION SFA trial have been presented for the first time at the Japan ...

May 30, 2023

Figure 1. Results from the PROTECT II RCT, PROTECT III and RESTORE-EF Pooled Data Analysis

News | Intra-Aortic Balloon Pumps (IABP)

Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI

May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that ...

May 19, 2023

Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.

News | Structural Heart

Data from Benchmark Registry Demonstrate Improved TAVR Efficiency with Preserved Patient Safety

May 17, 2023 — Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the ...

May 17, 2023

This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval

News | Drug-Eluting Balloons

MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

May 4, 2023 — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the Ca ...

May 04, 2023

According to a new release issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown

News | Intra-Aortic Balloon Pumps (IABP)

Datascope/Getinge Issues New Recall of Certain Cardiosave Hybrid and Rescue IABPs for Risk of Unexpected Shutdown

March 31, 2023 — According to statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

March 31, 2023

Late-breaking data presented at THT shows substantial fluid loss and improvements in kidney and cardiac function at 30 days after Aortix therapy

News | Heart Failure

Aortix Pump Therapy Leads to Rapid Decongestion and Improved Kidney Function in Hospitalized Patients with Heart Failure and Worsening Renal Function

March 21, 2023 — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac ...

March 21, 2023

Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because the coiled cable connecting the display and base on some units may fail, causing an unexpected shutdown

News | Intra-Aortic Balloon Pumps (IABP)

Datascope/Getinge Recalls Certain Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABP) for Risk of Unexpected Shutdown After Coiled Cord Connection Failure

March 20, 2023 — According to a statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

March 20, 2023

News | Drug-Eluting Balloons

Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study

March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coron ...

March 14, 2023

Single Intra-Myocardial Intervention with Rexlemestrocel-L Reduced Cardiovascular Death, Myocardial Infarction or Stroke Over Mean Follow-Up of 30 Months in High-Risk Patients with Chronic Heart Failure

News | Ventricular Assist Devices (VAD)

DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...

March 01, 2023

Featured presentation on the time to clinical benefit of sotagliflozin in people with worsening heart failure

News | Heart Failure

Abiomed at CRT 2023: Benefits of Impella-Supported High Risk PCI and Impella Innovation

February 24, 2023 — Abiomed, Inc., part of Johnson & Johnson MedTech[1], announced that results from a study on Impella ...

February 24, 2023

Harmony Transcatheter Pulmonary Valve System is the first FDA-approved minimally invasive valve designed for the right side of the heart

News | Congenital Heart

Medtronic Relaunches First-of-its-kind Transcatheter Pulmonary Valve Replacement System for Congenital Heart Disease

February 24, 2023 — Medtronic today announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a ...

February 24, 2023